Methyldopa hydrate

SKU: orb1301386

Description

Methyldopa hydrate is an antihypertensive agent that acts as a DOPA decarboxylase inhibitor and an indirect α2-adrenergic agonist. It reduces sympathetic outflow and catecholamine synthesis, and its NO-dependent sedative properties have been investigated in both in vivo and in vitro models of hypertension research.

Research Area

Metabolism Research, Neuroscience, Pharmacology & Drug Discovery

Key Properties

• CAS Number: 41372-08-1
• MW: 238.24
• Purity: 99.67% (May vary between batches)
• Formula: C₁₀H₁₃NO₄·3/2H₂O
• SMILES: O.C[C@](N)(Cc1ccc(O)c(O)c1)C(O)=O
• Target: Adrenergic Receptor,Endogenous Metabolite,Dopamine Receptor
• Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (8.39 mM);DMSO:12 mg/mL (50.37 mM)

Storage & Handling

• Storage: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

prodrug, response, α-Methyldopa Sesquihydrate, DOPA decarboxylase, DopamineReceptor, Dopamine Receptor, antihyoertensive, a-Methyldopa Sesquihydrate, Adrenergic Receptor, AdrenergicReceptor, MK351, MK-351, MK351 Hydrate, L-α-Methyldopa Hydrate, MK 351, MK 351 Hydrate, Methyldopa, metabolized, hyperglycemic, L-alpha-Methyldopa Hydrate, L-a-Methyldopa Hydrate

Compound Identifiers

PubChem CID

18530292